Evidence & Clinical Research

Articles examining preclinical findings, human studies, trial design, endpoints, limitations and the current state of clinical evidence.

Retatrutide: Mechanism, Clinical Research and Current Evidence

Leave a Comment / Evidence & Clinical Research, Peptide Profiles, Research Library /

Evidence reviewed: 22 July 2026 · Author: ExtolX Editorial Team · Scientific review: Pending Educational information for laboratory research audiences. This article does not provide medical advice, dosage or administration guidance. Retatrutide (LY3437943) is an investigational peptide designed to activate GIP, GLP-1 and glucagon receptors. It has progressed into Phase 3 research, but it is […]

Retatrutide: Mechanism, Clinical Research and Current Evidence Read More »

Semax: ACTH-Derived Peptide Research and Evidence Gaps

Leave a Comment / Evidence & Clinical Research, Peptide Profiles, Peptide Science, Research Library /

Evidence reviewed: 22 July 2026 · Author: ExtolX Editorial Team · Scientific review: Pending Educational information for laboratory research audiences. This article does not provide medical advice, dosage or administration guidance. Semax is a synthetic ACTH(4–7)-derived heptapeptide extended with Pro-Gly-Pro. Much of its published literature comes from Russian preclinical and regional clinical research. Key points

Semax: ACTH-Derived Peptide Research and Evidence Gaps Read More »

Selank: Tuftsin-Derived Peptide Research and Human Evidence

Leave a Comment / Evidence & Clinical Research, Peptide Profiles, Peptide Science, Research Library /

Evidence reviewed: 22 July 2026 · Author: ExtolX Editorial Team · Scientific review: Pending Educational information for laboratory research audiences. This article does not provide medical advice, dosage or administration guidance. Selank is a synthetic heptapeptide derived from the naturally occurring immunomodulatory peptide tuftsin. Published research examines stress, behaviour and gene expression, but high-quality human

Selank: Tuftsin-Derived Peptide Research and Human Evidence Read More »

PT-141 and Bremelanotide: From Melanocortin Research to Clinical Trials

Leave a Comment / Evidence & Clinical Research, Peptide Profiles, Research Library /

Evidence reviewed: 22 July 2026 · Author: ExtolX Editorial Team · Scientific review: Pending Educational information for laboratory research audiences. This article does not provide medical advice, dosage or administration guidance. PT-141 is an early research designation for bremelanotide, a cyclic melanocortin receptor agonist. A specific pharmaceutical formulation is FDA-approved in the United States, but

PT-141 and Bremelanotide: From Melanocortin Research to Clinical Trials Read More »

Melanotan II: Melanocortin Biology, Early Human Studies and Safety Questions

Leave a Comment / Evidence & Clinical Research, Peptide Profiles, Research Library /

Evidence reviewed: 22 July 2026 · Author: ExtolX Editorial Team · Scientific review: Pending Educational information for laboratory research audiences. This article does not provide medical advice, dosage or administration guidance. Melanotan II is a synthetic cyclic analogue of alpha-melanocyte-stimulating hormone. Human research is old and small, while unregulated use has generated important safety concerns.

Melanotan II: Melanocortin Biology, Early Human Studies and Safety Questions Read More »

CJC-1295 No DAC and Ipamorelin: Two Growth-Hormone Signalling Pathways

Leave a Comment / Evidence & Clinical Research, Peptide Profiles, Peptide Science, Research Library /

Evidence reviewed: 22 July 2026 · Author: ExtolX Editorial Team · Scientific review: Pending Educational information for laboratory research audiences. This article does not provide medical advice, dosage or administration guidance. CJC-1295-type peptides and ipamorelin act through different upstream receptors in growth-hormone research. Evidence for each compound should be separated from evidence for their combination.

CJC-1295 No DAC and Ipamorelin: Two Growth-Hormone Signalling Pathways Read More »